◆英語タイトル:BioPorto Diagnostics AS - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6401
◆発行会社(調査会社):
GlobalData
◆発行日:2018年10月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
BioPorto Diagnostics AS (BioPorto Diagnostics), formerly AntibodyShop AS is an in-vitro diagnostics company that manufactures and markets antibodies and antibody based products. The company’s products include matched reagent set, immunoassays, antigens, antibodies, controls calibrators and matched antibody pairs, among others. It also offers cell biology products, NGAL rapid ELISA Kit and Gc-globulin action free ELISA Kit, among others. BioPorto dDiagnostics offers various antibodies with specificity within medical specialties such as obesity, diabetes and primary immune deficiency. The company provides NGAL Test a diagnostic acute kidney injury biomarker which is measured in both human urine and plasma. It markets its products through sales channels and partners. BioPorto Diagnostics is headquartered in Copenhagen, Denmark.
BioPorto Diagnostics AS – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioPorto Diagnostics AS, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BioPorto Diagnostics AS, Medical Equipment Deals By Type, 2012 to YTD 2018 6
BioPorto Diagnostics AS, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BioPorto Diagnostics AS, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
BioPorto Diagnostics AS, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
BioPorto Diagnostics AS, Medical Equipment, Deal Details 10
Partnerships 10
BioPorto Diagnostics Enters Into Licensing Agreement With Abbott Labs 10
BioPorto Enters into Distribution Agreement with Roche Diagnostics 11
Equity Offering 12
BioPorto Diagnostics to Raise USD6.6 Million in Private Placement of Shares 12
BioPorto Diagnostics Raises USD3.2 Million in Private Placement of Shares 13
BioPorto Raises USD4.2 Million in Rights Offering of Shares 14
BioPorto Diagnostics Completes Rights Offering Of Shares For US$12.6 Million 15
BioPorto Diagnostics Completes Public Offering Of Shares For US$2 Million 16
BioPorto Diagnostics Completes Private Placement Of Shares For US$2 Million 17
BioPorto Diagnostics AS – Key Competitors 18
BioPorto Diagnostics AS – Key Employees 19
BioPorto Diagnostics AS – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Financial Announcements 21
Aug 16, 2018: BioPorto Group: Interim Report, Second Quarter 2018 21
May 03, 2018: BioPorto Reports First Quarter 2018 Results 23
Nov 07, 2017: BioPorto Announces Interim report, third quarter of 2017 24
Aug 10, 2017: BioPorto: Interim report, second quarter of 2017 25
May 04, 2017: BioPorto: Interim report, first quarter of 2017 26
Corporate Communications 27
Apr 18, 2018: BioPorto Names Ole Larsen As CFO 27
Jan 16, 2018: BioPorto Diagnostics: Changes in the Board of Directors 28
Jan 04, 2018: BioPorto: Changes in the Board of Directors 29
Product News 30
Jan 22, 2018: Launch of New Oxyntomodulin Antibodies (OXM) 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31
List of Tables
BioPorto Diagnostics AS, Medical Equipment, Key Facts 2
BioPorto Diagnostics AS, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
BioPorto Diagnostics AS, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BioPorto Diagnostics AS, Medical Equipment Deals By Type, 2012 to YTD 2018 6
BioPorto Diagnostics AS, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BioPorto Diagnostics AS, Deals By Market, 2012 to YTD 2018 8
BioPorto Diagnostics AS, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
BioPorto Diagnostics Enters Into Licensing Agreement With Abbott Labs 10
BioPorto Enters into Distribution Agreement with Roche Diagnostics 11
BioPorto Diagnostics to Raise USD6.6 Million in Private Placement of Shares 12
BioPorto Diagnostics Raises USD3.2 Million in Private Placement of Shares 13
BioPorto Raises USD4.2 Million in Rights Offering of Shares 14
BioPorto Diagnostics Completes Rights Offering Of Shares For US$12.6 Million 15
BioPorto Diagnostics Completes Public Offering Of Shares For US$2 Million 16
BioPorto Diagnostics Completes Private Placement Of Shares For US$2 Million 17
BioPorto Diagnostics AS, Key Competitors 18
BioPorto Diagnostics AS, Key Employees 19
List of Figures
BioPorto Diagnostics AS, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
BioPorto Diagnostics AS, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
BioPorto Diagnostics AS, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
BioPorto Diagnostics AS, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
BioPorto Diagnostics AS, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BioPorto Diagnostics AS, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
BioPorto Diagnostics AS, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BioPorto Diagnostics AS, Medical Equipment, Deals by Market, 2012 to YTD 2018 8